Evidence map›Paper›PMID 39010274›Full record

ArticleCell proliferation2024

Compromised cell competition exhausts neural stem cells pool.

Chenxiao Li, Mengtian Zhang, Yushan Du, Shuang Liu, Da Li, Shukui Zhang, Fen Ji, Jingjing Zhang, Jianwei Jiao

Abstract read
In one paragraph

Article in Cell proliferation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chenxiao LiAffiliated Hospital of Guangdong Medical University & Key Laboratory of Zebrafish Model for Development and Disease of Guangdong Medical University, Zhanjiang, China.
Mengtian ZhangKey Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Science, Beijing, China.
Yushan DuCollege of Basic Medicine, Qingdao University, Qingdao, China.
Shuang LiuJiaozuo Hospital of Traditional Chinese Medicine, Henan, China.
Da LiKey Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Science, Beijing, China.
Shukui ZhangKey Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Science, Beijing, China.
Fen JiKey Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Science, Beijing, China.
Jingjing ZhangAffiliated Hospital of Guangdong Medical University & Key Laboratory of Zebrafish Model for Development and Disease of Guangdong Medical University, Zhanjiang, China.
Jianwei JiaoKey Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Science, Beijing, China.ORCID https://orcid.org/0000-0002-7893-0721

Funding

National Natural Science Foundation of China 32230040National Natural Science Foundation of China 92149304National Natural Science Foundation of China 92368203
6 · The paper itself

Abstract

Blood vessels play a crucial role in maintaining the stem cell niche in both tumours and developing organs. Cell competition is critical for tumour progression. We hypothesise that blood vessels may act as a regulator of this process. As a pioneer, the secretions of blood vessels regulate the intensity of cell competition, which is essential for tumour invasion and developmental organ extension. Brd4 expresses highly in endothelial cells within various tumours and is positively correlated with numerous invasive genes, making it an ideal focal point for further research on the relationship between blood vessels and cell competition. Our results indicated that the absence of endothelial Brd4 led to a reduction in neural stem cell mortality and compromised cell competition. Endothelial Brd4 regulated cell competition was dependent on Testican2. Testican2 was capable of depositing Sparc and acted as a suppressor of Sparc. Compromised cell competition resulted in the depletion of neural stem cells and accelerated brain ageing. Testican2 could rescue the run-off of neural stem cells and accelerate the turnover rate of neurons. AD patients show compromised cell competition. Through the cloning of a point mutant of Brd4 identified in a subset of AD patients, it was demonstrated that the mutant lacked the ability to promote cell competition. This study suggests a novel approach for treating age-related diseases by enhancing the intensity of cell competition.

Indexed as

Cell CompetitionCell Cycle ProteinsNeural Stem CellsTranscription FactorsAnimalsBrainBromodomain Containing ProteinsEndothelial CellsHumansMiceNuclear ProteinsOsteonectinBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsNuclear ProteinsOsteonectinTranscription Factors

Identifiers

PMID39010274
PMCPMC11628731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.